|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs | |||||
| Right-of-use asset amortization | |||||
| Amortization of nonvested stock compensation expense | |||||
| Impairment of vessel assets | |||||
| Net gain on sale of vessels | |||||
| Loss on debt extinguishment | |||||
| Amortization of premium on derivatives | |||||
| Insurance proceeds for protection and indemnity claims | |||||
| Insurance proceeds for loss of hire claims | |||||
| Change in assets and liabilities: | |||||
| Decrease (increase) in due from charterers | |||||
| Increase in prepaid expenses and other current assets | |||||
| (Increase) decrease in inventories | |||||
| Increase (decrease) in accounts payable and accrued expenses | |||||
| Increase (decrease) in deferred revenue | |||||
| Decrease in operating lease liabilities | |||||
| Deferred drydock costs incurred | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of vessels and ballast water treatment systems, including deposits | |||||
| Purchase of other fixed assets | |||||
| Net proceeds from sale of vessels | |||||
| Insurance proceeds for hull and machinery claims | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the Revolver | |||||
| $600 Million Revolver | |||||
| $500 Million Revolver | |||||
| $450 Million Credit Facility | |||||
| Repayments to the Revolver | |||||
| $500 Million Revolver | |||||
| $450 Million Credit Facility | |||||
| Cash dividends paid | |||||
| Payment of deferred financing costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
Loading...